Purchase Order 75N95022P00201

Award Date 4/15/22
Potential Completion Date 4/14/25
Potential Value $492K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), awarded a $507,002.76 purchase order contract for consulting services to Shabas Solutions LLC, a woman-owned small business. The contract is to provide subject matter expert consulting services in the areas of pharmaceutics, formulation, and chemical manufacturing and controls (CMC) to support NIH programs such as the Blueprint Neurotherapeutics Network (BPN), the Helping to...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $524,788.00 contract to Shabas Solutions LLC, a minority-owned, woman-owned small business, to provide pharmaceutics formulation/chemistry manufacturing and controls consulting services for small molecules and/or biologics. The contract is a labor-hour purchase order set aside for small businesses. Shabas Solutions has over 15 years of experience...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $70,500 purchase order to Barbara Slusher, doing business as Slusher, Barbara, a woman-owned small business. This contract is set aside for total small businesses. The contract calls for pharmacology consulting services in support of the NIH Blueprint Neurotherapeutics Network drug discovery and development programs and associated External Oversight...
This is a $499,000 labor-hour purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to WHM Consulting, LLC, a self-certified small disadvantaged business. The contract is for assay development consultant support services to the NIH Blueprint Neurotherapeutics Network, which provides funding and expertise to neuroscience researchers for drug discovery and development projects. The contract has a one-year base...
This is a $6,000 firm-fixed-price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Hongjun Wang, a self-certified small disadvantaged business, for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products. The contract is a total small business set-aside under NAICS code 541690 (All Scientific and...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency of the U.S. government, awarded a $4,947,189.56 purchase order contract to Voisin Consulting, Inc. for biological therapeutics subject matter expert (SME) consulting services. The contract is a total small business set-aside with a performance period from April 2022 through April 2025. The SMEs will provide technical recommendations and advice to support the translational development of novel biologics for...
This is a $23,586.07 purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Shabas Solutions LLC, a small business consulting firm. The contract is for Chemistry Manufacturing Control (CMC), pharmaceutics, and formulation consultant support services to assist NIDA. The contract has a total small business set-aside designation and a period of performance through December 19, 2022. Shabas...
This is a $244,800 contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to RPK Associates, LLC, a small business. The contract is for biological therapeutics product development subject matter expert consulting services to support the development of cell and gene therapy products for NIH drug discovery and development programs, including the NIH Blueprint Neurotherapeutics Network Biologics (BPN-Biologics)...
The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $26,829 purchase order to Shabas Solutions LLC, a woman-owned small business consulting firm based in Fairfax, Virginia. The contract is for "Biologics SME Consulting Services" and has a period of performance through June 2, 2025. Shabas Solutions is certified as an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and a Women-Owned Small Business (WOSB), with additional small business...
This is a $444,500.00 labor-hour federal contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to In Vitro Strategies Limited Liability Company, a woman-owned small business. The contract is for the provision of senior-level consultant support services for bioactivity assay development to support the NINDS Blueprint Neurotherapeutics Program and other NIH neuroscience-focused drug development...

This is a $491,815.50 purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Shabas Solutions LLC, a woman-owned small disadvantaged business. The contract provides for subject matter expert consulting services to support the development of biological therapeutics for various NIH drug discovery and development programs, including the Blueprint Neurotherapeutics Network Biologics program, the NINDS Ultra-Rare Gene Therapy program, and the Helping to End Addiction Long-term Pain Therapeutics Development Program. The contract has a period of performance through April 14, 2025 and was set aside for small businesses.

Generated 7/23/24, 10:55 AM